- HealthinCode (“HiC”) Group is the Spanish leading platform in the non-reproductive genetic testing market focused on cardio and rare diseases. HiC Group is the result of the integration of Imegen, Genycell and HealthinCode; three of the largest, fast-growing, and most reputed genetic companies.
- Comprehensive business offering that meets clients’ internal and external demands of genetics through the distribution of genetic diagnostic equipment, the commercialization of diagnostic kits and the provision of analysis services.
- Creating the leading platform in the non-reproductive genetic testing market; a one-stop-shop in terms of genomic solutions.
- Establishing partnerships with large international players willing to introduce into the Spanish market new products or technologies.
- Fostering the adoption of genetic testing by the private healthcare sector.
- Strengthening HiC Group’s international presence.
- Investing in R&D to develop new products (e.g. kits) and services (e.g. pharmacogenetics) to keep up the pace with new market trends.
- Leading the consolidation play in a highly fragmented sector. Strategic focus on players that could either broaden the Group’s current product portfolio or grant access to new clients or geographies.